The AHA 2025 ACLS updates represent the most significant revision to Advanced Cardiovascular Life Support protocols in several years, and every healthcare provider preparing for certification or recertification needs to understand exactly what changed and why. The American Heart Association periodically revises its guidelines based on the most current resuscitation science, and the 2025 cycle introduces meaningful changes to cardiac arrest algorithms, post-resuscitation care, team dynamics, and medication dosing thresholds.

Whether you are a nurse, paramedic, physician, or respiratory therapist, these updates directly affect how you will be tested and how you should practice at the bedside. You can explore a comprehensive breakdown in the aha 2025 acls updates study hub for deeper algorithm walkthroughs.

One of the most headline-grabbing changes in the 2025 guidelines is the refined emphasis on high-quality CPR metrics. The AHA has narrowed the acceptable compression rate range, reinforced the importance of full chest recoil, and added new guidance on compression fraction targets during resuscitation efforts in both in-hospital and out-of-hospital cardiac arrest settings.

These changes are grounded in large-scale registry data showing that even small deviations from optimal compression depth and rate have measurable impacts on return of spontaneous circulation (ROSC) rates. For providers, this means that CPR feedback devices and real-time coaching tools are now considered best practice, not optional accessories.

The 2025 updates also refine the role of vasopressors and antiarrhythmics during cardiac arrest. Epinephrine remains the first-line vasopressor, but the updated guidelines provide clearer guidance on timing — particularly the recommendation to administer the first dose of epinephrine as early as possible in non-shockable rhythms, while continuing to prioritize defibrillation above all else in shockable rhythms like ventricular fibrillation and pulseless ventricular tachycardia. Amiodarone and lidocaine continue to hold their place in the algorithm for shock-refractory VF/pVT, but the evidence base supporting their use has been further scrutinized and contextualized.

Post-cardiac arrest care has received substantial attention in the 2025 revision cycle. The guidelines now include more specific targets for targeted temperature management (TTM), updated guidance on hemodynamic optimization after ROSC, and clearer recommendations around coronary angiography timing for survivors of out-of-hospital cardiac arrest without an obvious non-cardiac cause. The 2025 framework also places renewed emphasis on neuroprognostication, encouraging multidisciplinary teams to avoid premature withdrawal of life-sustaining treatment and to use a constellation of clinical, electrophysiological, and imaging data rather than any single marker.

Team dynamics and communication are woven throughout the 2025 ACLS updates in a way that previous editions only touched on tangentially. The AHA now explicitly describes the roles of team leader and team members with greater precision, and the updated provider course includes scenarios designed to test not just clinical knowledge but also closed-loop communication, constructive intervention, and situational awareness under stress. For certification candidates, this means that the written exam and the hands-on megacode skills stations will both assess teamwork behaviors alongside algorithm adherence and pharmacological decision-making.

Bradycardia and tachycardia algorithms have also seen clarification in the 2025 cycle. The unstable versus stable distinction remains the primary decision point, but the updated materials offer cleaner decision trees for specific rhythm subtypes, including third-degree AV block, wide-complex tachycardias of uncertain origin, and atrial fibrillation with rapid ventricular response in the setting of hemodynamic compromise. Providers who struggled with these branch points in earlier certification attempts will find the 2025 presentation more intuitive and clinically grounded.

Finally, the 2025 AHA updates include updated pediatric considerations within the ACLS framework, particularly for adolescent patients who bridge the gap between pediatric and adult resuscitation protocols. Weight-based dosing guidance has been refined, and the updated materials address situations where PALS and ACLS algorithms overlap or potentially conflict. Candidates preparing for the ACLS provider exam should pay particular attention to these boundary cases, as they frequently appear in both the written assessment and the scenario-based skills evaluation.

Understanding the specific changes to the cardiac arrest algorithm is the single most important preparation step for anyone sitting for the ACLS provider exam under the 2025 guidelines. The algorithm still branches at the fundamental question of whether the patient is in a shockable or non-shockable rhythm, but the 2025 revision introduces tighter decision-point language and updated timing guidance that providers must internalize.

In shockable rhythms — ventricular fibrillation and pulseless ventricular tachycardia — the sequence remains shock first, then resume CPR, then reassess. The 2025 update, however, places additional emphasis on minimizing the peri-shock pause to under five seconds when possible, citing registry data showing that longer pauses significantly reduce the probability of successful defibrillation.

For non-shockable rhythms — pulseless electrical activity and asystole — the 2025 guidelines bring the most notable change in medication timing. Previous editions allowed some flexibility in when to administer the first dose of epinephrine during non-shockable arrest. The 2025 update is more directive: epinephrine 1 mg IV or IO should be administered as soon as feasible after rhythm identification, with subsequent doses every three to five minutes throughout the resuscitation. This change reflects observational data and modeling studies suggesting that earlier epinephrine administration in PEA and asystole is associated with improved ROSC rates, particularly in prolonged arrests.

The 2025 ACLS update also refines how providers should approach reversible causes during cardiac arrest — the classic 5 Hs and 5 Ts framework. The updated materials present these causes in a more clinically actionable sequence, suggesting that providers simultaneously treat the most likely reversible cause while continuing high-quality CPR rather than pausing resuscitation to investigate. Ultrasound guidance for reversible cause identification is now explicitly endorsed in the 2025 guidelines when a trained operator is available and when its use does not interrupt chest compressions, reflecting widespread adoption of point-of-care ultrasound in emergency and critical care settings.

Defibrillation energy selection is another area that received clarifying language in 2025. For biphasic defibrillators, the recommendation is to use the manufacturer-recommended energy dose, typically 120 to 200 joules for the first shock. If that information is unavailable, providers should default to 200 joules. For subsequent shocks, the 2025 guidelines support either fixed or escalating energy strategies, deferring to device-specific manufacturer recommendations. Monophasic defibrillators should deliver 360 joules for all shocks. These recommendations are largely unchanged from previous cycles, but the 2025 materials present them with greater clarity to reduce provider hesitation during high-stress resuscitation scenarios.

Airway management during cardiac arrest has also been addressed in the 2025 updates, reflecting growing evidence that routine early endotracheal intubation during CPR does not improve outcomes compared to supraglottic airway devices or bag-mask ventilation in many settings.

The updated ACLS guidelines support a stepwise approach to airway management: begin with basic airway maneuvers and bag-mask ventilation, advance to a supraglottic device if BVM ventilation is inadequate, and proceed to endotracheal intubation when a highly experienced provider is available and when the intubation attempt will not disrupt chest compressions. This nuanced approach represents a meaningful departure from the historical default of immediate intubation in cardiac arrest.

The 2025 guidelines also introduce updated guidance on extracorporeal CPR, commonly called ECPR or ECMO-CPR, for select patients in refractory cardiac arrest. While ECPR is not universally available, the AHA now provides criteria for identifying candidates who may benefit — typically younger patients with witnessed arrest, shockable rhythms, and no obvious non-cardiac cause — and recommends that systems with ECPR capability develop defined activation protocols and transport criteria. For ACLS exam candidates at institutions that offer ECPR, understanding these criteria may be directly relevant to scenario-based testing questions.

Stroke response continues to be integrated into ACLS training, and the 2025 updates reinforce the critical importance of rapid identification using the Cincinnati Prehospital Stroke Scale or equivalent tools, immediate notification of the receiving facility, and minimizing door-to-CT and door-to-needle time for thrombolytic-eligible patients. The 2025 materials also address large vessel occlusion identification and the role of mechanical thrombectomy, reflecting the expansion of endovascular stroke care. ACLS providers working in emergency or prehospital settings should be familiar with their regional stroke system protocols and how they align with the updated AHA recommendations.

Post-cardiac arrest care is where many resuscitations are ultimately won or lost, and the 2025 AHA ACLS updates reflect a mature, evidence-based approach to the post-ROSC period that providers at all levels must understand. The overarching goal of post-arrest care is to optimize end-organ perfusion and prevent secondary brain injury while the underlying cause of arrest is identified and treated. The 2025 guidelines organize this care into several overlapping priorities: hemodynamic optimization, respiratory management, temperature management, coronary intervention, and neuroprognostication.

Hemodynamic targets after ROSC have been refined in the 2025 update. Providers should target a mean arterial pressure of at least 65 mmHg, though some evidence supports higher MAP targets of 80 to 100 mmHg in patients with known or suspected cardiac etiology, particularly those who remain comatose. Vasopressors — most commonly norepinephrine — are the first-line agents for post-arrest hypotension after volume status has been assessed. The 2025 materials discourage empirical fluid boluses without clinical or ultrasound evidence of volume depletion, reflecting concern about fluid overload in patients with myocardial dysfunction after cardiac arrest.

Respiratory management in the post-arrest period centers on two key targets: avoiding hyperoxia and avoiding hypoxia. The 2025 guidelines recommend titrating supplemental oxygen to maintain arterial oxygen saturation between 94% and 99% once reliable oximetry is available, rather than delivering 100% oxygen continuously. Hyperoxia has been associated with worse neurological outcomes in observational studies, while hypoxia is obviously harmful. Ventilation targets include normocapnia — a PaCO2 of 35 to 45 mmHg — as both hypo- and hypercapnia can adversely affect cerebral blood flow and outcome.

Targeted temperature management remains a cornerstone of post-arrest neuroprotection in the 2025 ACLS update, though the evidence base has evolved considerably. Following the TTM2 trial, which showed no benefit of 33°C compared to 37.5°C in comatose out-of-hospital cardiac arrest survivors, the 2025 guidelines have shifted toward recommending active prevention of fever — defined as a core temperature above 37.7°C — rather than mandatory cooling to 33°C for all patients. However, cooling to 32 to 36°C remains a reasonable option for select patients, particularly those in refractory shock or with specific clinical features suggesting increased benefit from hypothermia.

Coronary angiography timing for post-arrest patients without an obvious non-cardiac cause is another area where the 2025 guidelines provide clearer direction. Following several large randomized trials — most notably the TOMAHAWK and COACT trials — the guidelines no longer recommend emergent coronary angiography for all comatose OHCA survivors without ST-elevation on the post-ROSC ECG. Instead, coronary angiography should be performed urgently for patients with ST-elevation, hemodynamic instability suggesting cardiogenic shock, or other clinical features strongly suggesting acute coronary occlusion. For hemodynamically stable patients without ST-elevation, angiography can be deferred and performed during the same hospitalization after neurological assessment.

Neuroprognostication after cardiac arrest is one of the most clinically and ethically challenging aspects of post-arrest care, and the 2025 AHA guidelines address it with considerable nuance. The guidelines recommend that formal neuroprognostication be delayed until at least 72 hours after ROSC, and longer in patients who received targeted temperature management, because sedation and hypothermia can confound clinical examination findings. No single prognostic test is sufficient on its own — the 2025 framework recommends a multimodal approach incorporating clinical examination, EEG, somatosensory evoked potentials, brain imaging, and serum biomarkers such as neuron-specific enolase when available.

Team dynamics in post-arrest care are also emphasized in the 2025 ACLS materials. The period immediately following ROSC is often chaotic, with simultaneous demands for airway management, vascular access, hemodynamic monitoring, 12-lead ECG acquisition, and family communication. The updated provider course explicitly trains providers to maintain structured team communication during this transition, assign clear roles, and use closed-loop confirmation to ensure that critical interventions are not missed or duplicated. These soft skills are assessed during the megacode and clinical scenario components of the ACLS provider course.

Preparing strategically for the ACLS written exam and skills evaluation under the 2025 guidelines requires more than reading the provider manual once. The most successful candidates combine structured content review with active recall practice, simulation-based skill building, and targeted repetition of their weak areas. The written exam typically contains 50 multiple-choice questions covering algorithms, pharmacology, ECG interpretation, and clinical decision-making, and candidates must score at least 84% correct — 42 out of 50 — to pass. Understanding the exam format helps providers allocate their study time appropriately and avoid the common mistake of over-studying low-yield content while neglecting high-frequency topics.

ECG rhythm recognition is consistently one of the highest-yield areas on the ACLS written exam, and the 2025 updates reinforce its importance throughout the cardiac arrest and arrhythmia algorithms. Providers must be able to rapidly and accurately identify ventricular fibrillation, pulseless ventricular tachycardia, pulseless electrical activity, asystole, sinus bradycardia, complete heart block, atrial fibrillation with rapid ventricular response, stable SVT, and wide-complex tachycardia of uncertain origin.

Each of these rhythms has a distinct algorithm pathway, and confusing them under exam pressure is one of the most common sources of exam failure. Dedicated ECG practice — using strip-based flashcards, practice test questions, or digital rhythm trainers — is essential preparation.

Pharmacology questions make up a substantial portion of the written exam, and the 2025 updates introduce enough nuance in drug timing and selection to make careful review worthwhile. High-yield pharmacology topics include epinephrine dosing and timing in shockable versus non-shockable arrest, amiodarone and lidocaine indications and dosing for refractory VF/pVT, atropine for symptomatic bradycardia, adenosine for SVT, and dopamine or epinephrine infusions as transcutaneous pacing alternatives.

Providers who can articulate not just the dose but the rationale for each drug selection will perform significantly better on clinical reasoning questions that present a specific rhythm and clinical context and ask what to do next.

The megacode skills evaluation is the hands-on component of ACLS certification, and it is where providers most commonly struggle if they have not practiced the psychomotor components of resuscitation. The megacode scenario presents a simulated cardiac arrest that evolves through multiple rhythm changes and clinical decision points, requiring the provider to demonstrate correct algorithm execution, medication ordering, airway management decisions, and team leadership behaviors. The 2025 megacode framework is structured to assess whether the provider can identify rhythm transitions, call for appropriate interventions at the right times, and maintain situational awareness across a prolonged resuscitation scenario.

Practice test questions are one of the most efficient preparation tools available, provided they are written to reflect the 2025 guideline updates rather than older editions. Working through questions under timed conditions builds the cognitive fluency needed to perform well on exam day, and reviewing explanations for both correct and incorrect answer choices deepens understanding beyond surface-level memorization.

The most effective approach is to complete a practice question set, carefully review all explanations regardless of whether you answered correctly, and then return to the provider manual or study guide to consolidate understanding of the underlying concept before moving on to the next topic area.

Study groups and simulation-based practice are especially valuable for the team dynamics components of the 2025 ACLS course. Providers who practice megacode scenarios with colleagues before the certification day arrive with calibrated communication patterns, smoother role transitions, and greater confidence under the pressure of being evaluated. Even informal simulation practice — using a mannequin, an AED trainer, and a colleague to play team members — significantly reduces anxiety and improves performance on the day of certification. If formal simulation facilities are not available, video-based review of megacode scenarios can provide a useful mental model for what to expect.

Finally, candidates should be aware that the AHA offers both initial certification and renewal (recertification) pathways for ACLS, and the content tested may differ slightly based on which pathway a provider is taking. The 2025 updates apply to both initial and renewal candidates, but renewal courses may place greater emphasis on self-directed learning modules and skills verification rather than the full didactic curriculum. Regardless of pathway, every provider should enter their ACLS certification experience having reviewed the updated algorithms, practiced key medications, and worked through representative practice questions to confirm their readiness.

Building a practical, day-by-day study plan is the difference between feeling overwhelmed by the scope of the 2025 ACLS updates and feeling confident walking into the certification room. The most effective study plans share a few key characteristics: they prioritize high-yield content, they interleave active recall with content review, they include hands-on skill practice, and they build in buffer time for weak-area review before the exam date.

Providers who schedule their ACLS course four to six weeks out and study consistently for sixty to ninety minutes per day generally feel well-prepared; those who cram the night before struggle on both the written and skills evaluations.

In the first phase of preparation, focus exclusively on understanding the structural changes in the 2025 guidelines. Read the official AHA highlights document, which summarizes the key changes from the previous edition in a concise format. Create a mental map of the three core algorithms — cardiac arrest, bradycardia, and tachycardia — and note where the 2025 update differs from what you may have learned under prior editions.

Pay particular attention to epinephrine timing in PEA and asystole, the updated CPR quality metrics, and the new post-arrest care guidance, as these three areas generate the highest density of exam questions and the most meaningful clinical changes.

In the second phase, shift toward active recall and application. Work through practice questions organized by topic — algorithms first, then pharmacology, then ECG interpretation, then post-arrest care. When you miss a question, do not simply look up the answer and move on. Instead, trace the reasoning back to the algorithm or pharmacology principle that the question was testing, identify where your understanding broke down, and then practice that specific decision point until it becomes automatic. This approach takes more time than passive re-reading, but it produces dramatically better retention and performance on the actual exam.

In the third phase, simulate the exam and skills evaluation as realistically as possible. Take a full-length timed practice exam under conditions that approximate the actual test — no phone, no notes, sixty to ninety minutes at a single sitting. Review every question afterward, including the ones you answered correctly, because understanding why a correct answer is right is just as important as understanding why a wrong answer is wrong.

Then schedule at least one full megacode practice session with a colleague or simulation partner, ideally using a cardiac arrest scenario that transitions through a shockable rhythm to a non-shockable rhythm and then to ROSC, which is the most common megacode structure in ACLS provider courses.

On the day of your ACLS course, arrive with the algorithms memorized rather than planning to reference them during the course. Provider courses are designed for providers who have already done the background reading and practice, not for first-time encounters with the material.

Arrive rested, bring your provider manual if allowed, and approach the day with the mindset of demonstrating competence rather than learning from scratch. If you encounter a question or scenario that trips you up, note it carefully and review it thoroughly after the course — those gaps are precisely the areas where additional study will have the highest return before your next certification cycle.

After achieving ACLS certification, the work does not stop. The 2025 guidelines recommend that providers maintain familiarity with resuscitation algorithms between certification cycles, rather than allowing two years of disuse to erode their skills before the renewal course. Many healthcare systems support ongoing competency through simulation drills, code team participation, and regular review of cardiac arrest cases. Providers who actively participate in their institution's resuscitation quality improvement program — reviewing code metrics, debriefing after arrests, and updating team protocols — maintain higher skill levels and better patient outcomes than those who treat certification as a passive checkbox activity.

The 2025 AHA ACLS updates ultimately represent an investment in patient outcomes. Every change in the guidelines — from the epinephrine timing language to the post-arrest oxygen targets to the neuroprognostication framework — is grounded in evidence that directly affects whether patients survive cardiac arrest with intact neurological function.

Providers who take the time to understand not just what changed but why it changed will be better clinicians, better team members, and better advocates for their patients during the most critical moments of a clinical career. The certification exam is the gateway, but the real goal is bringing the best possible resuscitation science to every patient encounter.